Popular diabetes drug shown to lower inflammation, which may protect the heart
For the first time in a human trial, a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, already known for their weight-loss and glucose-lowering benefits, has also been shown ...
6 Oct 11:00 · Medical Xpress